To evaluate the ability of beta cell PAK1 enrichment to mitigate the negative effects of HFD-induced glucose intolerance and loss of functional beta cell mass in vivo, we used a novel Dox-inducible mouse model to express PAK1 in a beta cell-selective manner (Fig. 5a). The gene discussed is PAK1; the disease is Glucose intolerance.